Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Some people experienced hair loss after mesotherapy treatments for hair loss.

Ice-skating athletes often have skin problems due to cold, infections, and inflammation, needing careful treatment and prevention.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

The document suggests that the traditional understanding of hair growth cycles and alopecia may be inaccurate and that blood supply plays a significant role in hair growth and loss.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

People with HIV and low T cell counts have more hair and scalp problems.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Type I interferons play a key role in the development of various skin diseases.

New hair and skin changes were found in a rare case of syphilis-related hair loss.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Skin problems can be linked to sexual abuse, requiring careful medical and psychological evaluation.

Cetuximab can cause eyelash growth, which is rare but manageable.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.